TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results June 5, 1987